Technical Analysis for ASMB - Assembly Biosciences, Inc.

Grade Last Price % Change Price Change
grade C 23.08 3.96% 0.88
ASMB closed up 3.96 percent on Monday, August 3, 2020, on 84 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical ASMB trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Fell Below 50 DMA Bearish 3.96%
MACD Bearish Centerline Cross Bearish 3.96%
Stochastic Buy Signal Bullish 3.96%
Oversold Stochastic Weakness 3.96%
Bullish Engulfing Bullish 3.13%
Crossed Above 50 DMA Bullish 3.13%
Oversold Stochastic Weakness 3.13%
50 DMA Resistance Bearish 4.77%
Hammer Candlestick Bullish 4.77%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Assembly Biosciences, Inc. provides development and commercialization of gastrointestinal products in the United States. The company is developing two late-stage development product candidates, including VEN 307, a diltiazem cream for the relief of pain associated with anal fissures; and VEN 308, a phenylephrine gel for the treatment of fecal incontinence associated with ileal pouch anal anastomosis. It is also involved in the development of VEN 310 as a colonic delivery mechanism, which is a PH sensitive system to deliver bacteria, complex proteins, viral antigens, small molecules, and other treatments. The company was formerly known as Ventrus Biosciences Inc. and changed its name to Assembly Biosciences, Inc. in July, 2014. Assembly Biosciences, Inc. was founded in 2005 and is based in New York, New York.
Medicine Medical Specialties Gastroenterology Digestive System Digestive System Surgery Fecal Incontinence Gastrointestinal Products Large Intestine

Is ASMB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.84
52 Week Low 8.1301
Average Volume 223,461
200-Day Moving Average 18.73
50-Day Moving Average 22.43
20-Day Moving Average 23.64
10-Day Moving Average 23.16
Average True Range 1.50
ADX 20.08
+DI 25.71
-DI 23.93
Chandelier Exit (Long, 3 ATRs ) 23.34
Chandelier Exit (Short, 3 ATRs ) 25.21
Upper Bollinger Band 26.03
Lower Bollinger Band 21.24
Percent B (%b) 0.38
BandWidth 20.26
MACD Line -0.02
MACD Signal Line 0.29
MACD Histogram -0.3025
Fundamentals Value
Market Cap 400.76 Million
Num Shares 17.4 Million
EPS -2.93
Price-to-Earnings (P/E) Ratio -7.88
Price-to-Sales 176.68
Price-to-Book 9.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.72
Resistance 3 (R3) 24.57 23.88 24.44
Resistance 2 (R2) 23.88 23.46 23.95 24.35
Resistance 1 (R1) 23.48 23.21 23.68 23.63 24.26
Pivot Point 22.79 22.79 22.89 22.86 22.79
Support 1 (S1) 22.39 22.37 22.59 22.54 21.90
Support 2 (S2) 21.70 22.12 21.77 21.81
Support 3 (S3) 21.30 21.70 21.72
Support 4 (S4) 21.45